Clinical Trial Update: Nesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nesiritide infusion for decompensated heart failure with renal dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Renal Insufficiency

Drugs mentioned

• Nesiritide (recombinant human B-type natriuretic peptide (rhBNP))

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Congestive Heart Failure, Renal Insufficiency | Phase 2 | Status: COMPLETED